commences ind application for cvac, page-2

The promoters running PRR are doing an excellent job of ramping this one up. It will be an exciting ride for those who got in early.

In terms of actual milestones, I note that the company is not even close to BEGINING Phase IIb trials yet...they have only just agreed on the recruitment protocols.

There is a VERY long way to go before successful commericalisation...a few years yet. IF Phase IIb is successful, they then need to complete the tedious process of Phase III trials. That will cost a lot of money.

In the meantime...the price could go anywhere BEFORE those milestones are hit, so there could be quite a large profit for those patient, and who got in early.

Despite the attention of day traders, people prepared to HOLD PRR may see significant upside between now and moving into Phase III trials some years down the track.

Investors just need to be aware that this is still early stages, and high risks.

I am neither pumping this up, nor down ramping because I have seen biotechs soar much higher than 7.7c LONG BEFORE any commercial success is ever established.

Good luck to holders! It should be an exciting ride.